These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23069976)

  • 1. Telaprevir-induced pityriasis rubra pilaris-like drug eruption.
    Stalling SS; Vu JR; English JC
    Arch Dermatol; 2012 Oct; 148(10):1215-7. PubMed ID: 23069976
    [No Abstract]   [Full Text] [Related]  

  • 2. Sofosbuvir-Induced Erythrodermic Pityriasis Rubra Pilaris-Like Drug Eruption.
    Cheung EJ; Jedrych JJ; English JC
    J Drugs Dermatol; 2015 Oct; 14(10):1161-2. PubMed ID: 26461830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatological side-effects in hepatitis C infected patients under a triple regimen associating pegylated interferon, ribavirin and telaprevir.
    Bernardeschi C; Valeyrie-Allanore L; Ortonne N; Gressier L; Wallet-Faber N; Bernard PH; Hezode C; Duclos-Vallée JC; Samuel D; Mallet V; Pol S; Milpied B; Dupin N
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):143-6. PubMed ID: 25187266
    [No Abstract]   [Full Text] [Related]  

  • 4. Telaprevir-related dermatitis.
    Roujeau JC; Mockenhaupt M; Tahan SR; Henshaw J; Martin EC; Harding M; van Baelen B; Bengtsson L; Singhal P; Kauffman RS; Stern RS
    JAMA Dermatol; 2013 Feb; 149(2):152-8. PubMed ID: 23560295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe cutaneous eruptions on telaprevir.
    Chen ST; Wu PA
    J Hepatol; 2012 Aug; 57(2):470-2. PubMed ID: 22387663
    [No Abstract]   [Full Text] [Related]  

  • 6. Widespread morbilliform eruption associated with telaprevir: use of dermatologic consultation to increase tolerability.
    Strazzula L; Pratt DS; Zardas J; Chung RT; Thiim M; Kroshinsky D
    JAMA Dermatol; 2014 Jul; 150(7):756-9. PubMed ID: 24718650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail.
    Charlton M
    Hepatology; 2011 Jul; 54(1):3-5. PubMed ID: 21710471
    [No Abstract]   [Full Text] [Related]  

  • 8. Dermatological side effects of hepatitis C and its treatment: patient management in the era of direct-acting antivirals.
    Cacoub P; Bourlière M; Lübbe J; Dupin N; Buggisch P; Dusheiko G; Hézode C; Picard O; Pujol R; Segaert S; Thio B; Roujeau JC
    J Hepatol; 2012 Feb; 56(2):455-63. PubMed ID: 21884670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boceprevir and telaprevir in the management of hepatitis C virus-infected patients.
    Butt AA; Kanwal F
    Clin Infect Dis; 2012 Jan; 54(1):96-104. PubMed ID: 22156853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telaprevir-induced acquired perforating dermatosis.
    Pernet C; Pageaux GP; Guillot B; Dereure O; Bessis D
    JAMA Dermatol; 2014 Dec; 150(12):1371-2. PubMed ID: 25251868
    [No Abstract]   [Full Text] [Related]  

  • 11. [Perianal ulcerations with telaprevir].
    Awwad A; Renard P; Pouzoulet J; Sigal ML; Mahé E
    Ann Dermatol Venereol; 2012 May; 139(5):391-2. PubMed ID: 22578345
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies with telaprevir].
    MMW Fortschr Med; 2011 Jul; 153(29-31):15. PubMed ID: 21830727
    [No Abstract]   [Full Text] [Related]  

  • 13. First report of telaprevir-induced pancreatitis.
    Ventura C; Urich R; Skinner S; Bina R; Chuang KY; Van Thiel DH; Nadir A
    Dig Dis Sci; 2013 Mar; 58(3):887-8. PubMed ID: 23392743
    [No Abstract]   [Full Text] [Related]  

  • 14. Telaprevir and anaemia: what we learned from the first three patients.
    Sarikaya M; Doğan Z; Ergül B; Filik L
    Scand J Infect Dis; 2013 Jul; 45(7):575. PubMed ID: 23301829
    [No Abstract]   [Full Text] [Related]  

  • 15. Biphasic skin reactions during telaprevir-based therapy of Japanese patients infected with hepatitis C virus.
    Kishi A; Hayashi N; Ohara K; Aoki K; Yamada I; Ikeda K; Kumada H
    J Am Acad Dermatol; 2014 Mar; 70(3):584-6. PubMed ID: 24528908
    [No Abstract]   [Full Text] [Related]  

  • 16. High Frequency of Severe Telaprevir-associated Skin Eruptions in Clinical Practice.
    Carrascosa R; Capusan TM; Llamas-Velasco M; García-Buey L; Gordillo C; Sánchez-Pérez J
    Acta Derm Venereol; 2016 Jan; 96(1):97-9. PubMed ID: 26073421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of refractory telaprevir-induced dermatitis using oral corticosteroids.
    Garcias-Ladaria J; Pérez-Ferriols A; Ortega-García P; Diago M
    Actas Dermosifiliogr; 2014 Nov; 105(9):e55-60. PubMed ID: 24786187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virus.
    Gentile I; Carleo MA; Borgia F; Castaldo G; Borgia G
    Expert Opin Investig Drugs; 2010 Jan; 19(1):151-9. PubMed ID: 20001560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythema gyratum repens-like eruption occuring in resolving psoriasis during methotrexate therapy.
    Singal A; Sonthalia S; Pandhi D
    Int J Dermatol; 2010 Mar; 49(3):306-7. PubMed ID: 20465670
    [No Abstract]   [Full Text] [Related]  

  • 20. Study Results Support Telaprevir-Based Therapy for HCV.
    AIDS Patient Care STDS; 2010 Nov; 24(11):746. PubMed ID: 21108519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.